Search
Search
About
Log in
Join
Experiences with
Cobicistat
Posts
Communities
3 public posts
Filter results
Gilead Announces Phase 3 Results for Genvoya® (Elvitegravir, Cobicistat, etc.), an Investigational Once-Daily Single Tablet Regimen for HIV
http://www.natap.org/2015/EACS/EACS_01.htm
http://www.natap.org/2015/EACS/EACS_01.htm
kcohen
in
HFI Connect - Hepatitis
9 years ago
Gilead Seeks FDA OK for 3rd Combo Pill With New Tenofovir
The FDA is already reviewing two other TAF-inclusive combination tablets: an updated version of Stribild (elvitegravir/
cobicistat
/tenofovir/emtricitabine), which Gilead submitted to the agency in November 2014; and a new version of Truvada (tenofovir/emtricitabine), submitted in April 2015.
The FDA is already reviewing two other TAF-inclusive combination tablets: an updated version of Stribild (elvitegravir/
cobicistat
/tenofovir/emtricitabine), which Gilead submitted to the agency in November 2014; and a new version of Truvada (tenofovir/emtricitabine), submitted in April 2015.
kcohen
in
HFI Connect - Hepatitis
9 years ago
FDA Approves Two Combination Therapies for HIV
Evotaz by Bristol-Myers Squibb is a combination of 300 mg atazanavir (Reyataz, Bristol-Myers Squibb) and 150 mg
cobicistat
(a pharmacokinetic enhancer by Gilead Sciences), which should be used with other antiretroviral agents. Evotaz should be dosed once a day. Read more http://bit.ly/1yga8lR
Evotaz by Bristol-Myers Squibb is a combination of 300 mg atazanavir (Reyataz, Bristol-Myers Squibb) and 150 mg
cobicistat
(a pharmacokinetic enhancer by Gilead Sciences), which should be used with other antiretroviral agents. Evotaz should be dosed once a day. Read more http://bit.ly/1yga8lR
mwright
in
HFI Connect - Hepatitis
10 years ago
Want to take advantage of all our features? Just log in!
Log in
or
Join
Filter results
Clear filters
Posted in
All communities
HFI Connect - Hepatitis
3 results
Sort by
Most Relevant
Newest